Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...

Goldman Sachs boosts Bitcoin ETF investment with a 105% rise in holdings and strategic options, signaling institutional ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a ...

Shares of India's state-run oil refiners surged up to 5% after analysts at Macquarie and Goldman Sachs raised ratings and ...

U.S. bank executives said on Tuesday they expected policy uncertainty to linger as President Donald Trump's second ...

S&P 500 earnings per share could decline 1%-2% for each five percentage-point increase in the US tariff rate, Goldman Sachs ...

Goldman Sachs initiated coverage on Silence Therapeutics (NASDAQ:SLN), currently trading at $4.92 with a market cap of $232.3 million, with a Sell rating and a price target of $6.00. According to ...

Goldman Sachs upgraded Ultrapar from hold to buy. This strategy is highlighted by a target price reduction from R$25.10 to ...

Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...

We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...